IRWD

$0.00

(

0.00%

)
Quote details

stock

Ironwood Pharmaceuticals Inc

NASDAQ | IRWD

3.68

USD

$0.00

(

0.00%

)

At Close (As of Dec 11, 2025)

$598.66M

Market Cap

20.44

P/E Ratio

0.18

EPS

$5.13

52 Week High

$0.52

52 Week Low

HEALTHCARE

Sector

IRWD Chart

Recent Chart
Price Action

IRWD Technicals

Tags:

IRWD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $344M
Total Revenue $351M
Cost Of Revenue $7.6M
Costof Goods And Services Sold $7.6M
Operating Income $93M
Selling General And Administrative $144M
Research And Development $111M
Operating Expenses $251M
Investment Income Net -
Net Interest Income -$29M
Interest Income $4.5M
Interest Expense $33M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax $65M
Income Tax Expense $64M
Interest And Debt Expense -
Net Income From Continuing Operations $880K
Comprehensive Income Net Of Tax -
Ebit $96M
Ebitda $98M
Net Income $880K

Revenue & Profitability

IRWD Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $344M
Total Revenue $351M
Cost Of Revenue $7.6M
Costof Goods And Services Sold $7.6M
Operating Income $93M
Selling General And Administrative $144M
Research And Development $111M
Operating Expenses $251M
Investment Income Net -
Net Interest Income -$29M
Interest Income $4.5M
Interest Expense $33M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax $65M
Income Tax Expense $64M
Interest And Debt Expense -
Net Income From Continuing Operations $880K
Comprehensive Income Net Of Tax -
Ebit $96M
Ebitda $98M
Net Income $880K

IRWD News

IRWD Profile

Ironwood Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Ironwood Pharmaceuticals, Inc. is a prominent biotechnology firm headquartered in Boston, Massachusetts, specializing in the development and commercialization of innovative gastroenterological therapies. The company has a strong market presence driven by its flagship product, Linzess (linaclotide), and a robust pipeline aimed at addressing significant unmet medical needs in gastrointestinal disorders. Ironwood's strategic emphasis on research, development, and partnerships enhances its therapeutic offerings and positions it for sustainable growth, promising substantial long-term value for institutional investors while ultimately improving patient outcomes.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.